Previous Page  3 / 11 Next Page
Information
Show Menu
Previous Page 3 / 11 Next Page
Page Background

Page 30

Volume 2

DEMENTIA AND DEMENTIA CARE

ADVANCES IN ADDICTION SCIENCE AND MEDICINE

July 24-25, 2019 | Rome, Italy

10

th

International Conference on

2

nd

World Congress on

&

Addiction Science 2019 & Dementia Care 2019

July 24-25, 2019

Journal of Clinical Psychiatry and Neuroscience

Validation of a short telephone test (COGTEL) for the diagnosis of symptomatic

Alzheimer's disease (AD)

Maria Skondra

University of Patras, Greece

T

he identification of cognitive impairment in general practice requires short but accurate tests. For epidemiologic surveys

and genetic family studies cognitive tests are desirable which can be administered over the telephone. We assessed the

ability of the Greek version of the Cognitive Telephone Screening Instrument (COGTEL) to identify patients with symptomatic

Alzheimer's disease (AD) and compared it with the diagnostic accuracy of the conventional modified Mini Mental State

Examination (3MS). The study refers to 15 patients of the outpatient clinic for cognitive disorders of the University Hospital of

Patras who suffered from symptomatic Alzheimer’s disease (ten with mild dementia and five with mild cognitive impairment).

The study also included 17 cognitively unimpaired age-matched individuals. The COGTEL and 3MS were validated against an

expert diagnosis based on a comprehensive diagnostic workup which included the Montreal Cognitive Assessment (MoCA).

Statistical analysis was performed using the Receiver-Operator-Characteristics (ROC) method. The COGTEL outperformed the

3MS in the distinction between symptomatic AD and cognitively unimpaired individuals (Area under the curve, AUC: 0.92 vs.

0.89, respectively). The COGTEL is a short and practical but accurate telephone test for the identification of symptomatic AD for

use in epidemiological surveys and genetic family studies. The interview achieves higher diagnostic precision than the 3MS and

contributes to a valid assessment of cognitive performance.

Biography

Maria Skondra is a PhD candidate of the Medical Faculty of Medicine (University of Patras) and graduate of the Department of

Nursing (Western Greece University of Applied Sciences). Her scientific activity is focused on early diagnosis of cognitive impairment in

neurodegenerative neurocognitive disorders. She is a graduate of the Hellenic Red Cross Nursing School as well as of the Department

of Sociology (Panteion University of Athens). She completed postgraduate studies at the Department of Social and Educational Policy

of the University of Peloponnese with specialization in the field of "Health Institutions and Policies". She has been working as a nurse

in the Greek Red Cross since 2001 and as scientific scholar of the Department of Nursing (Western Greece University of Applied

Sciences) since 2016.

mskon@hotmail.gr

J Clin Psychiatr Neurosci, Volume 2